Journal of Developing Drugs
Open Access
ISSN: 2329-6631
+44 20 3868 9735
ISSN: 2329-6631
+44 20 3868 9735
Department of Medicine, THQ Hospital Talagang, Talagang, Pakistan
Research Article
Mortality in Patients of COVID-19 when given Remdesivir in Early Stages of the Disease as Compared to Late Stages of the Disease in Pakistani Population
Author(s): Zahabia Manzoor, Haaris Inam Khan*, Saddiq ul Abidin, Fatima Maqsood, Ahsan Farooq Khan, Syed Muhammad Sikandar, Alina Fakhar and Khalid Shahzad
Background: Various drugs have been studied in the management of COVID-19 infection and the only antiviral that has been proven efficacious is Remdesivir which is a broad spectrum antiviral agent having activity against RNA dependent viral RNA polymerase.
Objective: To compare the frequency of mortality in patients of COVID-19 when given Remdesivir in early stages of the disease as compared to the late stages of the disease.
Study design: Retrospective comparative cross sectional study. Study setting Farooq hospital Lahore, Pakistan.
Study duration: 12 Months.
Data analysis: All patients admitted from January 2020 till December 2020 above 18 years of age of either gender diagnosed COVID-19 positive by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) with.. Read More»
DOI:
10.35248/ 2329-6631.22.11.175
